Premark Pharma
1 known investors
Premark Pharma develops ophthalmic formulations of pimecrolimus, a topical anti-inflammatory compound, to treat blepharitis, dry eye, and ocular surface inflammation. The company aims to obtain marketing approvals for these eye-disease treatments in the EU and US.
BiotechMedical Devices
Investors · 1
Frequently asked questions
- What does Premark Pharma do?
- Premark Pharma develops ophthalmic formulations of pimecrolimus, a topical anti-inflammatory compound, to treat blepharitis, dry eye, and ocular surface inflammation. The company aims to obtain marketing approvals for these eye-disease treatments in the EU and US.
- Who are Premark Pharma's investors?
- Premark Pharma's investors include OphthaFund.